Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 ...

Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly ...

Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...

Objectives To characterise the aetiological spectrum of thoracic granulomatous diseases and identify diagnostic features that facilitate differentiation among causes. Design Retrospective multicentre ...